Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Blue Bird Corp
(NQ:
BLBD
)
38.34
+0.49 (+1.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
473,382
Open
37.85
Bid (Size)
38.33 (1)
Ask (Size)
38.34 (25)
Prev. Close
37.85
Today's Range
37.40 - 38.80
52wk Range
17.37 - 37.85
Shares Outstanding
27,204,435
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning
Today 10:33 EDT
Via
Investor Brand Network
Topics
Energy
Exposures
Fossil Fuels
Is NASDAQ:BLBD suited for growth investing?
March 26, 2024
High growth, ROE and beating expectations for NASDAQ:BLBD: growth investors may appreciate this.
Via
Chartmill
Performance
YTD
+45.72%
+45.72%
1 Month
+18.77%
+18.77%
3 Month
+36.05%
+36.05%
6 Month
+86.39%
+86.39%
1 Year
+88.50%
+88.50%
More News
Read More
7 EV Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Via
InvestorPlace
NASDAQ:BLBD, a growth stock which is not overvalued.
March 26, 2024
Via
Chartmill
3 Promising Small-Cap Stocks Packing a Powerful Punch
March 23, 2024
Via
InvestorPlace
Beat Wall Street: 3 Stocks Flying Under the Radar
March 05, 2024
Via
InvestorPlace
Is NASDAQ:BLBD a Fit for Growth Investing Strategies?
March 05, 2024
Via
Chartmill
NASDAQ:BLBD is not too expensive for the growth it is showing.
March 05, 2024
Via
Chartmill
What 4 Analyst Ratings Have To Say About Blue Bird
February 29, 2024
Via
Benzinga
Blue Bird Corp. (NASDAQ: BLBD) Sets New 52-Week High in Friday Session
March 01, 2024
Via
Investor Brand Network
Topics
Energy
Exposures
Fossil Fuels
7 Must-Buy Stocks for a Diversified High-Growth Portfolio
March 01, 2024
Via
InvestorPlace
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
February 27, 2024
Via
Newsfile
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Should you consider NASDAQ:BLBD for growth investing?
February 13, 2024
Via
Chartmill
NASDAQ:BLBD stands out as a growth opportunity that won't break the bank.
February 13, 2024
Via
Chartmill
Wall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024
February 23, 2024
Via
InvestorPlace
Topics
Electric Vehicles
Exposures
Electric Vehicles
3 Goliath Growth Stocks Poised for Takeoff in February
February 19, 2024
Via
InvestorPlace
Blue Bird Announces Launch of Secondary Public Offering
February 15, 2024
From
Blue Bird Corporation
Via
Business Wire
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Via
MarketBeat
Exposures
Product Safety
Blue Bird: Q1 Earnings Insights
February 07, 2024
Via
Benzinga
Win-Win Situation? Nuvve's (NASDAQ: NVVE) Technology Can Potentially Turn Your Electric Vehicle Into A Revenue Stream That Helps Support The Power Grid
February 14, 2024
Via
Benzinga
Topics
Electric Vehicles
Emissions
Exposures
Electric Vehicles
Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning
February 08, 2024
Via
Investor Brand Network
Topics
Energy
Exposures
Fossil Fuels
12 Industrials Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Blue Bird Reports Fiscal 2024 First Quarter Record Results; Raises 2024 Guidance
February 07, 2024
From
Blue Bird Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.